NIP
KRTX

Nicholas Investment Partners’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

Nicholas Investment Partners’s Portfolio KRTX Stock Details KRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-9,644
Closed -$3.05M – 230
2023
Q4 		$3.05M Sell
9,644
-82,457
-90% -$16M 0.36% 109
2023
Q3 		$15.6M Sell
92,101
-63,829
-41% -$12M 1.16% 30
2023
Q2 		$33.8M Buy
155,930
+108
+0.1% +$23.1K 2.31% 8
2023
Q1 		$28.3M Buy
155,822
+58,694
+60% +$11.2M 2.15% 9
2022
Q4 		$19.1M Buy
97,128
+19,874
+26% +$4.26M 1.67% 12
2022
Q3 		$17.4M Buy
77,254
+21,493
+39% +$4.35M 1.61% 11
2022
Q2 		$7.05M Buy
55,761
+35,572
+176% +$4.09M 0.67% 51
2022
Q1 		$2.56M Buy
+20,189
New +$2.27M 0.18% 133

Other funds holding KRTX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
S
Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

Nicholas Investment Partners's KRTX Position: Q1 2024 in Review

Nicholas Investment Partners sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q1 2024, closing a stake of 9,644 shares — an estimated $3.05M sold.

Nicholas Investment Partners first reported a position in KRTX in Q1 2022 and held it in 8 quarters. The position peaked at $33.8M in Q2 2023. 2 funds tracked by Wall St. Rank hold KRTX as of Q1 2024.

  • Nicholas Investment Partners reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Nicholas Investment Partners sold 9,644 Karuna Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $3.05M.
  • Nicholas Investment Partners first reported a position in Karuna Therapeutics, Inc. Common Stock in Q1 2022 and held it in 8 quarters.
  • Nicholas Investment Partners's Karuna Therapeutics, Inc. Common Stock position peaked at $33.8M in Q2 2023.
  • 2 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Nicholas Investment Partners's 13F filing for Q1 2024, filed 14 May 2024.